TechnoMark News

The factors contributing to the growth of remdesivir market include, rising number of coronavirus disease (COVID-19) and increasing government initiatives. The advantages of remdesivir observed during the trails such as shortened time of recovery by an average of four days is another key factor driving its demand. Agreements signed by Gilead with generic manufacturers to deliver treatment at a substantially lower cost in the developing countries is also anticipated to boost the market growth during the forecast period. However, the possibility of shortage of the drug and the concerns related to the safety and efficacy of remdesivir amongst the patient population are some factors that are likely to hinder the market growth to a certain extent. Major Key Players of the Remdesivir Market are: Gilead Sciences, Inc., BrightGene Bio-Medical Technology Co.,Ltd., Hainan Haiyao Co., Ltd., EVA PHARM, Cipla Inc., Mylan N.V., Hetero, Ferozsons Laboratories, Zydus Cadila, Dr. Reddy’s Laboratories L...

Remdesivir is a less popular drug for antiviral medication, which has become the first medicine approved by the FDA for treating the novel Coronavirus in May 2020. Previously, the drug Remdesivir was regarded as an investigational drug. The drug was never used to treat any disease or any medical condition. Today, the drug is being studied as a probable treatment for several diseases. In the beginning, the drug was created as a potential treatment for hepatitis. The drug was studied as a potential treatment for Ebola virus in 2014. Since then, the effectiveness of the drug has been studied as treatment for any other viruses other than the novel Coronavirus. Also, researchers have found that Remdesivir drug has been proved to be effective against several other (SARS) severe acute respiratory syndrome and also (MERS) Middle East respiratory syndrome, despite the studies were done in the test-tubes and not in animals but on animals. The drug, when used on Coronavirus affected people preven...

“Remdesivir Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020–2030” suggests that global remdesivir market is expected to witness substantial CAGR from 2020 to 2030. The factors contributing to the growth of remdesivir market include, rising number of coronavirus disease (COVID-19) and increasing government initiatives. The advantages of remdesivir observed during the trails such as shortened time of recovery by an average of four days is another key factor driving its demand. Agreements signed by Gilead with generic manufacturers to deliver treatment at a substantially lower cost in the developing countries is also anticipated to boost the market growth during the forecast period. However, the possibility of shortage of the drug and the concerns related to the safety and efficacy of remdesivir amongst the patient population are some factors that are likely to hinder the market growth to a certain extent. Major Key Players of the Remdesivir Market are: ...

The initial novel coronavirus outbreak in China led to COVID-19 pandemic. COVID-19 has rapidly affected millions of lives worldwide thereafter. For instance, in U.S by the end of June 2020 there were approximately 3.1 million total cases with active cases being around 1.5 million. Rapid surge in the number of COVID-19 cases is expected to drive the growth of remdesivir market. Moreover, results from the NIAID study on patients hospitalized with COVID-19 showcased that remdesivir shortened time to recovery by an average of four days. This positive result is expected to spur its demand in the coming years. The Remdesivir Market is segmented on the basis of Form, Patient Type, Application and region. Major Form of Remdesivir Market covered are: Lyophilized Powder Concentrated Solution Major Patient Type of Remdesivir Market covered are: Pediatric Patient Adult Patients Major End Users of Remdesivir Market covered are: Hospitals Clinics Moreover, amidst the current COVID-19 pandemic, there...

Remdesivir is a less popular drug for antiviral medication, which has become the first medicine approved by the FDA for treating the novel Coronavirus in May 2020. Previously, the drug Remdesivir was regarded as an investigational drug. The drug was never used to treat any disease or any medical condition. Today, the drug is being studied as a probable treatment for several diseases. In the beginning, the drug was created as a potential treatment for hepatitis. The drug was studied as a potential treatment for Ebola virus in 2014. Since then, the effectiveness of the drug has been studied as treatment for any other viruses other than the novel Coronavirus. Also, researchers have found that Remdesivir drug has been proved to be effective against several other (SARS) severe acute respiratory syndrome and also (MERS) Middle East respiratory syndrome, despite the studies were done in the test-tubes and not in animals but on animals. Major Key Players of the Remdesivir Market are: Gilead Sc...

“Remdesivir Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020–2030” suggests that global remdesivir market is expected to witness substantial CAGR from 2020 to 2030. The factors contributing to the growth of remdesivir market include, rising number of coronavirus disease (COVID-19) and increasing government initiatives. The advantages of remdesivir observed during the trails such as shortened time of recovery by an average of four days is another key factor driving its demand. Agreements signed by Gilead with generic manufacturers to deliver treatment at a substantially lower cost in the developing countries is also anticipated to boost the market growth during the forecast period. However, the possibility of shortage of the drug and the concerns related to the safety and efficacy of remdesivir amongst the patient population are some factors that are likely to hinder the market growth to a certain extent. Major Key Players of the Remdesivir Market are: ...